Vascular complications in diabetes: old messages, new thoughts Josephine M. ForbesAmelia K. Fotheringham Review 19 July 2017 Pages: 2129 - 2138
Understanding and preventing type 1 diabetes through the unique working model of TrialNet Manuela BattagliaMark S. AndersonMark Peakman Review Open access 02 August 2017 Pages: 2139 - 2147
Should we screen for type 2 diabetes among asymptomatic individuals? Yes David SimmonsJanice C. Zgibor Commentary 23 August 2017 Pages: 2148 - 2152
Does the evidence support population-wide screening for type 2 diabetes? No Jonathan E. Shaw Commentary 23 August 2017 Pages: 2153 - 2156
Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial Klemen DovcMaddalena MacedoniTadej Battelino Article Open access 24 August 2017 Pages: 2157 - 2167
Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement Timothy J. McDonaldRachel E. BesserAndrew T. Hattersley Article Open access 05 August 2017 Pages: 2168 - 2173
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine Antonio EleuteriAnthony C. Fisherfor the Individualised Screening for Diabetic Retinopathy (ISDR) Study Group Article Open access 24 August 2017 Pages: 2174 - 2182
Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults Rebecca K. SimmonsSimon J. GriffinAnnelli Sandbæk Article Open access 23 August 2017 Pages: 2183 - 2191
Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009 Rebecca K. SimmonsSimon J. GriffinAnnelli Sandbæk Article Open access 23 August 2017 Pages: 2192 - 2199
Screening for type 2 diabetes: do screen-detected cases fare better? Adina L. FeldmanSimon J. GriffinOlov Rolandsson Article Open access 23 August 2017 Pages: 2200 - 2209
The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study Lin XuMaria Carolina BorgesDebbie A. Lawlor Article Open access 09 September 2017 Pages: 2210 - 2220
Perceived racism and incident diabetes in the Black Women’s Health Study Kathryn L. BaconSherri O. StuverEdward A. Ruiz-Narváez Short Communication 15 August 2017 Pages: 2221 - 2225
Immigration to Israel during childhood is associated with diabetes at adolescence: a study of 2.7 million adolescents Alon PeledBarak GordonArnon Afek Short Communication 19 August 2017 Pages: 2226 - 2230
Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes Adem Y. DawedAshfaq AliPaul W. Franks Article Open access 25 August 2017 Pages: 2231 - 2239
Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion Felicia GerstRobert WagnerDorothea Siegel-Axel Article 08 August 2017 Pages: 2240 - 2251
Relapsing/remitting type 1 diabetes Kayleigh M. van MegenMatthew P. SpindlerBart O. Roep Short Communication Open access 23 August 2017 Pages: 2252 - 2255
The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse Danielle J. BorgRan WangSumaira Z. Hasnain Article Open access 04 August 2017 Pages: 2256 - 2261
VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells Gaia BotteriMarta MontoriManuel Vázquez-Carrera Article 23 August 2017 Pages: 2262 - 2273
FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes Thomas LaegerChristian BaumeierAnnette Schürmann Article Open access 02 August 2017 Pages: 2274 - 2284
Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes Cristina HernándezPatricia BogdanovRafael Simó Article 04 August 2017 Pages: 2285 - 2298
Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor Abigail C. LayJenny A. HurcombeRichard J. M. Coward Article Open access 29 August 2017 Pages: 2299 - 2311
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy Chinmay S. MaratheChristopher K. RaynerMichael Horowitz Letter 12 August 2017 Pages: 2312 - 2313
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy. Reply to Marathe CS, Rayner CK, Jones KL, et al [letter] Adam D. FarmerAnne Grave PedersenChristina Brock Letter 17 September 2017 Pages: 2314 - 2315